Identification of cytochrome c oxidase subunit 6A1 as a suppressor of Bax-induced cell death by yeast-based functional screening

被引:24
作者
Eun, So Young [1 ]
Woo, Im Sun [1 ]
Jang, Han-Su [2 ]
Jin, Hana [1 ]
Kim, Min Young [1 ]
Kim, Hye Jung [1 ]
Lee, Jae Heun [1 ]
Chang, Ki Churl [1 ]
Kim, Jin-Hoi [3 ]
Seo, Han Geuk [1 ]
机构
[1] Gyeongsang Natl Univ, Sch Med, Gyeongsang Inst Hlth Sci, Dept Pharmacol, Jinju 660751, South Korea
[2] Gyeongbuk Inst Bioind, Dept Res & Dev, Andong 760380, South Korea
[3] Konkuk Univ, Dept Anim Biotechnol, Seoul, South Korea
关键词
4-HPR; COX6A1; ROS; apoptosis; Bax; JNK;
D O I
10.1016/j.bbrc.2008.05.178
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human cytochrome c oxidase subunit VIa polypeptide 1 (COX6A1) was identified as a novel Suppressor of Bcl-2-associated X protein (Bax)-mediated cell death using yeast-based functional screening of a mammalian cDNA library. The overexpression of COX6A1 significantly suppressed Bax- and N-(4-hydroxyphenyl)retinamide (4-HPR)-induced apoptosis in yeast and human glioblastoma-derived U373MG cells, respectively. The generation of reactive oxygen species (ROS) in response to Bax or 4-HPR was inhibited in yeast and U373MG cells that expressed COX6A1, indicating that COX6A1 exerts a protective effect against ROS-induced cell damage. 4-HPR-induced mitochondrial translocation of Bax, release of mitochondrial cytochrome c, and activation of caspase-3 were markedly attenuated in U373MG cells that stably expressed COX6A1. Our results demonstrate that yeast-based functional screening of human genes for inhibitors of Bax-sensitivity in yeast identified a protein that not only suppresses the toxicity of Bax in yeast, but also has a potential role in protecting mammalian cells from 4-HPR-induced apoptosis. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:58 / 63
页数:6
相关论文
共 25 条
[1]   The chemopreventive agent N-(4-hydroxyphenyl) retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family [J].
Boya, P ;
Morales, MC ;
Gonzalez-Polo, RA ;
Andreau, K ;
Gourdier, I ;
Perfettini, JL ;
Larochette, N ;
Deniaud, A ;
Baran-Marszak, F ;
Fagard, R ;
Feuillard, J ;
Asumendi, A ;
Raphael, M ;
Pau, B ;
Brenner, C ;
Kroemer, G .
ONCOGENE, 2003, 22 (40) :6220-6230
[2]   HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma [J].
Brezniceanu, ML ;
Völp, K ;
Bösse, S ;
Solbach, C ;
Lichter, P ;
Joos, S ;
Zörnig, M .
FASEB JOURNAL, 2003, 17 (08) :1295-+
[3]  
ELBLE R, 1992, BIOTECHNIQUES, V13, P18
[4]   Nuclear genes for cytochrome c oxidase [J].
Grossman, LI ;
Lomax, MI .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1997, 1352 (02) :174-192
[5]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[6]   The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases [J].
Kadenbach, B ;
Arnold, S ;
Lee, I ;
Hüttemann, M .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2004, 1655 (1-3) :400-408
[7]   N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells [J].
Kim, HJ ;
Chakravarti, N ;
Oridate, N ;
Choe, C ;
Claret, FX ;
Lotan, R .
ONCOGENE, 2006, 25 (19) :2785-2794
[8]   Vesicle-associated membrane protein of Arabidopsis suppresses Bax-induced apoptosis in yeast downstream of oxidative burst [J].
Levine, A ;
Belenghi, B ;
Damari-Weisler, H ;
Granot, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (49) :46284-46289
[9]   Fenretinide: a prototype cancer prevention drug [J].
Malone, W ;
Perloff, M ;
Crowell, J ;
Sigman, C ;
Higley, H .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (11) :1829-1842
[10]   Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons:: implications for free radical generation and oxidative damage in disease progression [J].
Manczak, M ;
Anekonda, TS ;
Henson, E ;
Park, BS ;
Quinn, J ;
Reddy, PH .
HUMAN MOLECULAR GENETICS, 2006, 15 (09) :1437-1449